Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Shingles Vaccine's Next Stop Is CDC Panel After US FDA Approval

Oct 24 2017

• By Brenda Sandburg

Shingrix Zoster Vaccine

Related Content

Shingrix Shingles Vaccine: FDA Wants GSK To Monitor Inflammation Risk

Sep 12 2017

GSK's Shingrix Shingles Vaccine Awaiting Final Labeling Tweaks

Sep 14 2017

GSK Shingrix Shingles Vaccine Seen Displacing Zostavax After US FDA Approval

Oct 23 2017

Related Companies

GSK plc

Merck & Co., Inc.

Agenus Inc.

Additional Topics

United States Approvals Vaccines Market Access Reimbursement Government Payers Infectious Diseases BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window